The results showed that as the melanoma progressed, the expression of malignant progression marker genes (pmel, mlana, sox10, cdk4, zeb1, and vim) significantly increased, with notable expression differences observed among benign nevi, dysplastic nevi, and invasive melanoma (Figure 3D). This evidence concerns the gene SOX10 and dysplastic nevus.